AIDS Healthcare Foundation

Los Angeles, California 90211

0 studies enrolling now · 36 studies all time

What they study most

AIDS/HIV PROBLEM, Chlamydia Trachomatis, Disease Transmission, Infectious, Gonorrhea, HIV, HIV Infections, Hepatitis C, Infections, Safe Sex, Sarcoma, Kaposi, Sexually Transmitted Diseases

Studies at this site

• Cabenuva Injection Tracking in CHORUS — Completed
• Hepatitis C Diagnosis to Treatment Management — Completed
• Hepatitis C Screening Alerts — Completed
• Evaluation of the Atlas Genetics io® CTNG System — Completed
• Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV — Completed
• Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients — Completed
• Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r — Completed
• Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors — Completed
• BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. — Completed
• BRAVO: Background Regimen of Raltegravir on Virologic Outcome — Completed
• Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy — Completed
• Eban II: Intervention for HIV Sero-Discordant Couples — Status unconfirmed
• Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients — Completed
• Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen — Completed
• Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment — Completed
• Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) — Completed
• A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs — Completed
• A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) — Completed
• A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients — Completed
• A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy — Completed
• A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment — Completed
• T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs — Completed
• Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs — Status unconfirmed
• A Comparison of 141W94 and Indinavir in HIV-Infected Patients — Completed
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir) — Status unconfirmed
• Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs — Completed
• Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients — Completed
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs — Completed
• A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations — Completed
• Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults — Completed
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients — Completed
• A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients — Completed
• The Effect of Teaching HIV-Infected Patients About HIV and Treatment — Completed
• A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients — Completed
• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs — Status unconfirmed
• Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors — Status unconfirmed